rdoe_persona_userprofile
rdoe_persona_select_up

AVENIO Tumor Tissue Targeted Kit V2

For Research Use Only. Not for use in diagnostic procedures.

AVENIO Tumor Tissue Targeted Kits
Overview

The AVENIO Tumor Tissue Targeted Kit V2 is a next-generation sequencing (NGS) research assay for genomic profiling of solid tumors from formalin-fixed paraffin-embedded (FFPE) tissue samples. It contains 17 guideline-aligned biomarkers, including those in the U.S. National Comprehensive Cancer Network (NCCN) Guidelines.

 

Features and Benefits

 

  • Panel content exactly-matched to gene panel in the AVENIO ctDNA Targeted Kit V2 (same genes, gene regions and hybrid-capture workflow) to facilitate analytical concordance between tissue and plasma
  • All four mutation classes (SNVs, indels, fusions and CNVs) in a single DNA workflow
  • Flexibility to switch between tissue and plasma to support a variety of research applications
  • A streamlined, end-to-end research workflow from extraction to analysis and reporting in 5 days
  • A complete research solution that includes reagents, intuitive analysis and reporting to facilitate in-house adoption of high performance NGS oncology testing

Exceptional Performance1

To place an order or ask a question
Contact us

References

  1. Data on file with Roche.
  2. National Comprehensive Cancer Network. Accessed Aug 2, 2023.